Keywords
Last Name
Institution

Michael J. Donovan

TitleSENIOR FACULTY
InstitutionMount Sinai
DepartmentPathology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD, Haroutunian V, Zhu J, Donovan MJ, Sharp AJ, Casaccia P. Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains. Nat Neurosci. 2014 Jan; 17(1):121-30.
      View in: PubMed
    2. Cravedi P, Leventhal J, Lakhani P, Ward SC, Donovan MJ, Heeger PS. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity. Am J Transplant. 2013 Oct; 13(10):2530-9.
      View in: PubMed
    3. Donovan MJ, Cordon-Cardo C. Predicting high-risk disease using tissue biomarkers. Curr Opin Urol. 2013 May; 23(3):245-51.
      View in: PubMed
    4. Donovan MJ, Costa J, Cordon-Cardo C. Personalized approach to prostate cancer prognosis. Arch Esp Urol. 2011 Oct; 64(8):783-91.
      View in: PubMed
    5. Graversen JA, Suh LK, Mues AC, Korets R, Donovan MJ, Khan FM, Liu Q, Landman J, Gupta M, McKiernan JM, Badani KK. Independent diagnostic and post-treatment prognostic models for prostate cancer demonstrate significant correlation with disease progression end points. J Endourol. 2012 May; 26(5):451-6.
      View in: PubMed
    6. Donovan MJ, Khan FM, Powell D, Bayer-Zubek V, Cordon-Cardo C, Costa J, Eastham J, Scardino P. Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10-year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery. BJU Int. 2012 Jan; 109(1):40-5.
      View in: PubMed
    7. Donovan MJ, Khan FM, Bayer-Zubek V, Powell D, Costa J, Cordon-Cardo C. A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer. BJU Int. 2012 Jan; 109(2):207-13.
      View in: PubMed
    8. Kim HS, Moreira DM, Jayachandran J, Gerber L, Bañez LL, Vollmer RT, Lark AL, Donovan MJ, Powell D, Khan FM, Freedland SJ. Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men. Prostate Cancer Prostatic Dis. 2011 Sep; 14(3):262-5.
      View in: PubMed
    9. Donovan MJ, Costa J, Cordon-Cardo C. Personalized approach to prostate cancer prognosis. Minerva Urol Nefrol. 2010 Sep; 62(3):231-9.
      View in: PubMed
    10. Donovan MJ, Osman I, Khan FM, Vengrenyuk Y, Capodieci P, Koscuiszka M, Anand A, Cordon-Cardo C, Costa J, Scher HI. Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease. BJU Int. 2010 Feb; 105(4):462-7.
      View in: PubMed
    11. Donovan MJ, Costa J, Cordon-Cardo C. Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology. Cancer. 2009 Jul 1; 115(13 Suppl):3078-84.
      View in: PubMed
    12. Donovan MJ, Khan FM, Fernandez G, Mesa-Tejada R, Sapir M, Zubek VB, Powell D, Fogarasi S, Vengrenyuk Y, Teverovskiy M, Segal MR, Karnes RJ, Gaffey TA, Busch C, Haggman M, Hlavcak P, Freedland SJ, Vollmer RT, Albertsen P, Costa J, Cordon-Cardo C. Personalized prediction of tumor response and cancer progression on prostate needle biopsy. J Urol. 2009 Jul; 182(1):125-32.
      View in: PubMed
    13. Donovan MJ, Kotsianti A, Bayer-Zubek V, Verbel D, Teverovskiy M, Cordon-Cardo C, Costa J, Greco FA, Hainsworth JD, Parums DV. A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib. Eur J Cancer. 2009 May; 45(8):1518-26.
      View in: PubMed
    14. Eggener SE, Vickers AJ, Serio AM, Donovan MJ, Khan FM, Bayer-Zubek V, Verbel D, Cordon-Cardo C, Reuter VE, Bianco FJ, Scardino PT. Comparison of models to predict clinical failure after radical prostatectomy. Cancer. 2009 Jan 15; 115(2):303-10.
      View in: PubMed
    15. Donovan MJ, Hamann S, Clayton M, Khan FM, Sapir M, Bayer-Zubek V, Fernandez G, Mesa-Tejada R, Teverovskiy M, Reuter VE, Scardino PT, Cordon-Cardo C. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. J Clin Oncol. 2008 Aug 20; 26(24):3923-9.
      View in: PubMed
    16. Cordon-Cardo C, Kotsianti A, Verbel DA, Teverovskiy M, Capodieci P, Hamann S, Jeffers Y, Clayton M, Elkhettabi F, Khan FM, Sapir M, Bayer-Zubek V, Vengrenyuk Y, Fogarsi S, Saidi O, Reuter VE, Scher HI, Kattan MW, Bianco FJ, Wheeler TM, Ayala GE, Scardino PT, Donovan MJ. Improved prediction of prostate cancer recurrence through systems pathology. J Clin Invest. 2007 Jul; 117(7):1876-83.
      View in: PubMed
    17. Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon-Cardo C, Beug H, Grünert S. Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest. 2006 Jun; 116(6):1561-70.
      View in: PubMed
    18. Capodieci P, Donovan M, Buchinsky H, Jeffers Y, Cordon-Cardo C, Gerald W, Edelson J, Shenoy SM, Singer RH. Gene expression profiling in single cells within tissue. Nat Methods. 2005 Sep; 2(9):663-5.
      View in: PubMed
    Donovan's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067